FRMs, sometimes referred to as field reimbursement specialists or patient experience specialists, are the key drivers in patient pre-authorization and billing and coding processes, and play a vital role in the prescription and adoption of specialty drugs. While field reps focus on selling, FRMs focus solely on supporting healthcare provider (HCP) offices and helping office staff get past complex processes and procedures that can hinder speed-to-therapy for patients. Challenges Facing FRMs The highly technical nature of the FRM role is already challenging and becomes further complicated by a lack of connectivity and process inefficiency with hub and data and analytics teams. Manufacturers and life sciences companies realize that connectivity for […]
What Is Market Shaping?
As the leader of integrated commercialization partnerships, EVERSANA is redefining how pharma manufacturers prepare the market for the launch or repositioning of their products. Market shaping is necessary to develop a market need for the therapy and build brand awareness across an array of stakeholders.
Our deep bench of industry experts across every facet of commercialization – market access, value and evidence, patient services, regulatory, marketing and sales, data and analytics, market research, global pricing and creative – collectively develop a compelling brand value story that will resonate with patients, providers and payers. This holistic approach better informs pre-launch, launch and post-launch strategies and tactics to heighten awareness and promote therapy uptake.
Synthesize & Right-Size Your Resources
Value-driven launch strategies must go beyond traditional sales territory mapping, target lists, training and tactical value propositions. EVERSANA’s compelling brand value story, coupled with the holistic and effective coordination of frontline teams – sales team, telesales, medical science liaisons (MSLs), clinical nurse educators (CNEs) and reimbursement specialists – ensures the right patients get the right therapy at the right time. With the right targeting and proper training in hybrid models, you don’t need to assume that an “army” of reps is the only option to market shaping.
Manufacturers now have a new opportunity to optimize stakeholder engagement and convert virtual and in-person interactions into scripts sooner. In doing so, manufacturers have the ability to “right-size” NAMs, KAMs, FRMs, MSLs and CNEs, giving them access to leverage actionable data, optimize connectivity and execute across the ecosystem – the key to success.
Why Is EVERSANA the Best Partner in Market Shaping?
There are so many interdependencies in the “Market Shaping Ecosystem.” At EVERSANA, our teams work together to align, adopt and adapt to the everchanging dynamics of the complex pharma industry. Our market-shaping team of experts work symbiotically with our partners to develop, optimize and pivot strategies to ensure commercialization success.
How Do We Do It?
Take a sneak peek into the elements impacting the Market Shaping Activation Model by exploring our featured content.